EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of the Therapeutic Potential of Synthetic Growth Hormone-Releasing Hormone Antagonist MIA-690 as a Cognitive Modulator in a Mouse Model of Gulf War Illness

Luis Manuel Salgueiro-Tosta, Arumugam Radhakrishnan Jayakumar iD, William Kochen iD, Renzhi Cai, Wei Sha, Erik Johnson, James O'Callaghan, Miklós Jászberényi iD, Andrew Victor Schally, Nancy Klimas iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26178516 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Luis Manuel Salgueiro-Tosta und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Neuro Immune Medicine, Nova Southeastern University, Davie, FL 33314, USA. Hauptthemen laut MEDLINE: Growth Hormone-Releasing Hormone, Synthetic Drugs, Peptides, Persian Gulf Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States Department of Defense, Gulf War Illness Research Program (GWIRP), Congressionally Directed Medical Research Program (CDMRP), U.S. Department of Defense, the resources of the Institute for Neuro-Immune Medicine at Nova Southeastern University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gulf War illness (GWI) is a multi-symptom disorder affecting veterans of the Persian Gulf operations. Persistent neuroendocrine dysregulation contributes to impairing cognitive capacity and generates anxiety-like behavior. Effective treatments for this illness are challenging due to compromised metabolism, increased oxidative stress and neuroinflammation, perpetuated by chronic stress and hypothalamic–pituitary–adrenal (HPA) axis dysfunction. This neuroinflammation can be alleviated with synthetic antagonistic analogs of the growth hormone-releasing hormone (GHRH) through modulation of the HPA axis. We evaluated the efficacy of the GHRH antagonist analog, MIA-690, against cognitive impairment and anxiety-like behavior in GWI. Mice exposed to an experimental GWI model involving corticosterone (CORT) and diisopropylfluorophosphate (DFP), followed by CORT and lipopolysaccharide (LPS), received a daily subcutaneous dose of 10 μg of MIA-690 for 10 days. Assessments of spatial memory, recognition capacity, somatic health, anxiety and innate survival were carried out, combining the Morris water maze (MWM), novel object recognition (NORT), grip strength (GST), and open field (OFT) tests. Learning efficiency was selectively enhanced in females using the MWM. There were no significant differences in the recall capacity and performance on the OFT, NOR, and GST tasks. Our findings suggest that the MIA-690 dosage is sufficient to improve learning deficits in experimental GWI exposures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Growth Hormone-Releasing HormoneSynthetic DrugsPeptidesPersian Gulf SyndromeCognitive DysfunctionDisease Models, AnimalCognitionAnxietyCorticosteroneIsoflurophateLipopolysaccharidesMaleFemaleAnimalsMiceMice, Inbred C57BLMaze LearningSpatial Memory

Stichwörter der Autor:innen

Gulf War illnessMorris water mazegrip strength testgrowth hormone-releasing hormonehypothalamic–pituitary–adrenal axisneurodegenerationneuroinflammationnovel object recognition testopen field test

Substanzen

Growth Hormone-Releasing HormoneMIA-690Synthetic DrugsPeptidesCorticosteroneIsoflurophateLipopolysaccharides

Autor:innen und Institutionen

  • Institute for Neuro Immune Medicine, Nova Southeastern University, Davie, FL 33314, USA.
  • Endocrine, Polypeptide and Cancer Institute, Miami VA Healthcare System, Miami, FL 33125, USA.
  • Department of Obstetrics, Gynecology and Reproductive Sciences, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Department of Neuroscience, High Point University, High Point, NC 27262, USA.
  • U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010, USA.
  • Molecular Neurotoxicology Laboratory, Centers for Disease Control, Morgantown, WV 26505, USA.

ORCID-Profile: Arumugam Radhakrishnan Jayakumar, William Kochen, Miklós Jászberényi, Nancy Klimas

Förderung

  • United States Department of Defense
  • Gulf War Illness Research Program (GWIRP), Congressionally Directed Medical Research Program (CDMRP), U.S. Department of Defense
  • the resources of the Institute for Neuro-Immune Medicine at Nova Southeastern University
  • the Research Services at the Veterans Affairs Department
  • the Miami VA Healthcare System
  • the South Florida Veterans Affairs Foundation for Research and Education Inc.

Zitieren

APA

Salgueiro-Tosta, L. M., Jayakumar, A. R., Kochen, W., Cai, R., Sha, W., Johnson, E., O'Callaghan, J., Jászberényi, M., Schally, A. V., & Klimas, N. (2025). Evaluation of the Therapeutic Potential of Synthetic Growth Hormone-Releasing Hormone Antagonist MIA-690 as a Cognitive Modulator in a Mouse Model of Gulf War Illness. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178516

Vancouver

Salgueiro-Tosta LM, Jayakumar AR, Kochen W, Cai R, Sha W, Johnson E, et al. Evaluation of the Therapeutic Potential of Synthetic Growth Hormone-Releasing Hormone Antagonist MIA-690 as a Cognitive Modulator in a Mouse Model of Gulf War Illness. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178516

BibTeX
@article{SalgueiroTosta2025,
  author = {Salgueiro-Tosta, Luis Manuel and Jayakumar, Arumugam Radhakrishnan and Kochen, William and Cai, Renzhi and Sha, Wei and Johnson, Erik and O'Callaghan, James and Jászberényi, Miklós and Schally, Andrew Victor and Klimas, Nancy},
  title = {Evaluation of the Therapeutic Potential of Synthetic Growth Hormone-Releasing Hormone Antagonist MIA-690 as a Cognitive Modulator in a Mouse Model of Gulf War Illness},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26178516}
}
Kostenlos starten →